Anxiolytic profile of the antiepileptic drug levetiracetam in the Vogel conflict test in the rat

European Journal of Pharmacology

Volumn 469, Issue 1-3, 2003, Pages 97-102

  Lamberty, Yves ^a   Falter, Ursula ^a   Gower, Alma J ^a   Klitgaard, Henrik ^a  

^a UCB PHARMA   (Belgium)

Author keywords

Antiepileptic; Anxiety; Anxiolytic effect; Chlordiazepoxide; Levetiracetam; Vogel conflict test

Indexed keywords

ANTICONVULSIVE AGENT; CHLORDIAZEPOXIDE; ETIRACETAM; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICIPATION; ANXIETY; APPARATUS; ARTICLE; CONDITIONED REFLEX; CONFLICT; CONTROLLED STUDY; DRINKING; DRUG ACTIVITY; DRUG ADMINISTRATION ROUTE; DRUG EFFECT; DRUG SCREENING; ELECTRIC SHOCK; EXPERIMENT; EXPERIMENTAL MODEL; FEAR; HABITUATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; TIME; TRANQUILIZING ACTIVITY; WATER DEPRIVATION;

EID: 0037716316     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01724-2     Document Type: Article

References (31)

1. Birnstiel S., Wulfert E., Beck S.G. Levetiracetam (ucb L059) affects in vitro models of epilepsy in CA3 pyramidal neurons without altering normal synaptic transmission. Naunyn-Schmiedeberg's Arch. Pharmacol. 356:1997;611-618.
2. Dalvi A., Rogers R.J. Anxiolytic effects of valproate and diazepam are differentially sensitive to picrotoxin antagonism. Pharmacol. Biochem. Behav. 68:2001;23-32.
3. Dantzer R. Behavioral analysis of anxiolytic drug action. Greenshaw A.J., Dourish C.T. Experimental Psychopharmacology. 1987;263-297 Humana Press, Clifton, NJ.
4. De-Paris F., Busnello J.V., Vianna M.R., Salgueiro J.B., Quevedo J., Izquierdo I., Kapczinski F. The anticonvulsant compound gabapentin possesses anxiolytic but not amnesic effects in rats. Behav. Pharmacol. 11:2000;169-173.
5. File S.E., Aranko K. Sodium valproate and chlordiazepoxide in the elevated plus-maze test of anxiety in the rat. Neuropsychobiology. 20:1988;82-86.
6. Gower A.J., Hirsch E., Boehrer A., Noyer M., Marescaux C. Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy. Epilepsy Res. 22:1995;207-213.
7. Griebel G. 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research. Pharmacol. Ther. 65:1995;319-395.
8. Izumi T., Inoue T., Tsuchiya K., Hashimoto S., Ohmori T., Koyama T. Effects of the benzodiazepine antagonist flumazenil on conditioned fear stress in rats. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 23:1999;1247-1258.
9. Jetty P.V., Charney D.S., Goddard A.W. Neurobiology of generalized anxiety disorder. Psychiatr. Clin. North Am. 24:2001;75-97.
10. Klitgaard H., Matagne A., Gobert J., Wulfert E. Evidence for a unique preclinical profile of levetiracetam in rodents models of seizure and epilepsy. Eur. J. Pharmacol. 353:1998;191-206.
11. Klitgaard H., Matagne A., Lamberty Y. Use of epileptic animals for adverse effect testing. Epilepsy Res. 50:2002;55-65.
12. Korte S.M. Corticosteroids in relation to fear, anxiety and psychopathology. Neurosci. Biobehav. Rev. 25:2001;117-142.
13. Lamberty Y., Margineanu D.G., Klitgaard H. Absence of negative impact of levetiracetam on cognitive function and memory in normal and amygdala-kindled rats. Epilepsy Behav. 1:2000;333-342.
14. Lamberty Y., Margineanu D.G., Klitgaard H. Effect of the new antiepileptic drug levetiracetam in an animal model of mania. Epilepsy Behav. 2:2001;454-459.
15. Lamberty Y., Gower A.J., Klitgaard H. The new antiepileptic drug levetiracetam normalises chlordiazepoxide withdrawal-induced anxiety in mice. Eur. J. Pharmacol. 439:2002;101-106.
16. LeDoux J.E. Emotion: clues from the brain. Annu. Rev. Psychol. 46:1995;209-235.
17. Lee C., Rodgers R.J. Effects of benzodiazepine receptor antagonist, flumazenil, on antinociceptive and behavioural responses to the elevated plus-maze in mice. Neuropharmacology. 30:1991;1263-1267.
18. A receptor-associated epileptiform effect of bicuculline in rat hippocampus. Br. J. Pharmacol. 122:1997;1146-1150.
19. Margineanu D.G., Klitgaard H. Levetiracetam mechanism of action. Lévy R.H., Mattson R.H., Meldrum B.S., Perucca E. Antiepileptic Drugs. 5th ed. 2002;419-427 Lippincott Williams & Wilkins, Philadelphia.
20. Moshé S.L. Mechanisms of action of anticonvulsant agents. Neurology. 55(Suppl. 1):2000;32-40.
21. 2+ current in pyramidal neurons of rat hippocampal slices. Neurosci. Lett. 306:2001;5-8.
22. Pain L., Launoy A., Fouquet N., Oberling P. Mechanisms of action of midazolam on expression of contextual fear in rats. Br. J. Anaesth. 89:2002;614-621.
23. Pollard G.T., Howard J.L. Effects of drugs on punished behavior: pre-clinical test for anxiolytics. Pharmacol. Ther. 45:1990;403-424.
24. Rigo J.M., Hans G., Nguyen L., Rocher V., Belachew S., Malgrange B., Leprince P., Moonen G., Selak I., Matagne A., Klitgaard H. The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents. Br. J. Pharmacol. 136:2002;659-672.
25. Schulkin J., McEwen B.S., Gold P.W. Allostasis, amygdala, and anticipatory angst. Neurosci. Biobehav. Rev. 18:1994;385-396.
26. Singh L., Field M.J., Ferris P., Hunter J.C., Oles R.J., Williams R.G., Woodruff G.N. The antiepileptic agent gabapentin (neurontin) possesses anxiolytic-like and antinociceptive actions that are reverse by D-serine. Psychopharmacology. 127:1996;1-9.
27. Taylor C.P. Gabapentin mechanism of action. Lévy R.H., Mattson R.H., Meldrum B.S., Perucca E. Antiepileptic Drugs. 5th ed. 2002;321-334 Lippincott Williams & Wilkins, Philadelphia.
28. Treit D. Animal models for the study of anti-anxiety agents: a review. Neurosci. Biobehav. Rev. 9:1985;203-222.
29. Verloes R., Scotto A.M., Gobert J., Wulfert E. Effect of nootropic drugs in a scopolamine-induced amnesia model in mice. Psychopharmacology (Berl.). 95:1988;226-230.
30. Vogel J.R., Beer B., Clody D.E. A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacologia. 21:1971;1-7.
31. 2+ currents. Seizure. 10:2001;279-286.